CI Stock Recent News

Cigna beat Wall Street estimate for second-quarter profit on Thursday, helped by strength in its pharmacy benefit management business.

Total revenues for the second quarter 2025 increased 11% to $67.2 billion Shareholders' net income for the second quarter 2025 was $1.5 billion, or $5.71 per share Adjusted income from operations1 for the second quarter 2025 was $1.9 billion, or $7.20 per share Reaffirms 2025 outlook for adjusted income from operations1,2 of at least $29.60 per share2 BLOOMFIELD, Conn. , July 31, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) today reported strong second quarter 2025 results, reflecting continued growth and solid performance across its diverse portfolio of businesses.

CI's Q2 results are likely to hinge on Evernorth's growth as core healthcare revenues and premiums face steep declines.

Umer Raffat, Evercore ISI senior analyst, joins 'The Exchange' to discuss if there's a turnaround coming for the health care sector.

Sufficient earnings growth to continually increase dividends at a comfortably low payout  ratio that also accommodates expansion capex is an excellent signal for strong upside potential.

Molina Healthcare Inc. MOH missed Wall Street expectations in its second-quarter earnings report Wednesday, triggering a selloff across the healthcare insurance sector.

Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BLOOMFIELD, Conn. , July 22, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.51 per share of its common stock, payable on September 18, 2025 to shareholders of record as of the close of business on September 4, 2025.

I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate and another comparing each stock's forward dividend yield with its 5-year average dividend yield. To rank stocks, I do a quality assessment and sort candidates by quality scores, breaking ties with additional metrics.

A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecasts. Of the eight largest publicly traded US managed care insurers, all but two — UnitedHealth Group and Alignment Healthcare — are projected to report lower revenue compared with Q1 2025, while all eight are forecast to log higher revenue than Q2 2024. In Q2, all eight of the largest publicly traded US managed care insurers, except The Cigna Group, are expected to log lower net income sequentially, while all eight are forecast to report lower net income YoY.